|Bid||8.76 x 3100|
|Ask||8.77 x 1300|
|Day's Range||8.47 - 8.83|
|52 Week Range||6.25 - 13.76|
|Beta (5Y Monthly)||1.48|
|PE Ratio (TTM)||2,190.00|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 27, 2017|
|1y Target Est||12.19|
Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - October 28, 2020) - If you suffered losses exceeding $50,000 investing in Teva stock or options between October 29, 2015 and August 18, 2020 and would like to discuss your legal rights, click here: www.faruqilaw.com/TEVA or call Faruqi & Faruqi partner James Wilson directly at 877-247-4292 ...
New York, New York--(Newsfile Corp. - October 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE: TEVA) between October 29, 2015 and August 18, 2020, inclusive (the "Class Period"), of the important November 23, 2020 lead plaintiff deadline in securities class action. The lawsuit seeks to recover damages for Teva investors under the federal securities laws.To join the Teva ...
Another thing volatility tends to do is highlight value stocks that are on sale. Proven businesses are often a great place to park your money when short-term emotions get the better of Wall Street. With this in mind, the following four top value stocks are on sale right now and are just begging to be bought.